Label reads in part as: "GRAVIOLA EXTRACT***1 FL Oz — Class I food recall F-3245-2015
Terminated recall by Majopa Industries Corporation, reported 2015-09-30, distributed in PR. Firm's dietary supplements were being promoted for conditions that caused the products to be drugs under the F
| Recall number | F-3245-2015 |
|---|---|
| Product type | Food |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Majopa Industries Corporation, Guayama, PR, United States |
| Recall initiated | 2015-07-31 |
| Classified | 2015-09-22 |
| Reported by FDA | 2015-09-30 |
| Terminated | 2017-03-29 |
| Distributed | PR |
| Quantity | 500 bottles |
Product
Label reads in part as: "GRAVIOLA EXTRACT***1 FL Oz (30 ml)*** ORIGINAL FORMULA***Manufactured by: Majopa Industries Corp.*** PRODUCT OF PUERTO RICO,USA". Drug claims in the product label are as follows: "Researchers have found that Extracts from Graviola leaves can produce acetogenins which are extremely effective in the treatment of cancer cells. Graviola extract can works like an antibiotic against cancer cells by stopping growth of the enzymes needed for cell growth. It can be:cellular protector, anti tumorous, antiviral. Also can be used as: Digestive stimulant, Strengthens immune system, antifungal, tranquilizer".
Reason for recall
Firm's dietary supplements were being promoted for conditions that caused the products to be drugs under the FD&C Act.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/F-3245-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.